Aptamer Group PLC (AIM:APTA)

Market Cap	28.99M
Revenue (ttm)	1.20M
Net Income (ttm)	-2.42M
Shares Out	2.70B
EPS (ttm)	-0.00
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	961,976
Average Volume	6,256,398
Open	1.022
Previous Close	1.075
Day's Range	1.000 - 1.150
52-Week Range	0.231 - 1.570
Beta	0.71
RSI	69.92
Earnings Date	Mar 11, 2026

About Aptamer Group

Aptamer Group PLC, together with its subsidiaries, provides synthetic binders for research, diagnostics, and therapeutics in the United Kingdom, rest of Europe, the United States, and internationally. The company offers Optimer, a platform that enables the discovery and development of optimized DNA and RNA aptamers, which can bind to target molecules. Its platform is used in research reagent and analytical, bioprocessing, diagnostic, cosmetic and consumer health, and therapeutic applications. The company serves pharmaceutical, diagnostic, and b...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2008
• Employees: 31
• Stock Exchange: London Stock Exchange AIM
• Ticker Symbol: APTA

Financial Performance

In 2025, Aptamer Group's revenue was 1.20 million, an increase of 39.88% compared to the previous year's 860,000. Losses were -2.42 million, -18.05% less than in 2024.